It's interesting how the placebo affect is so strong. They should have had a third group that did no placebo or treatment to compare rates with the null case (s

It's interesting how the placebo affect is so strong. They should have had a third group that did no placebo or treatment to compare rates with the null case (since the placebo doesn't really qualify as a null case here). > The most recent drug trial found that more than 86 percent of those who took MDMA achieved a measurable reduction in severity of their PTSD symptoms. About 71 percent of participants improved enough that they no longer met the criteria for a diagnosis. Of those who took the placebo, 69 percent improved and nearly 48 percent no longer qualified for a PTSD diagnosis, according to the submitted data.